Maria Goulielmaki

12PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersInnate immunityRadiation therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 28, 2026
Peripheral T-Cell Receptor β Repertoire Dynamics Correlate with Response to Anti-PD-L1 Therapy in Non-Small Cell Lung Cancer.

|Jul 13, 2024
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Anastasia Xagara, Maria Goulielmaki, Sotirios P Fortis

|Jul 29, 2023
Correction: Kogionou et al. Radiotherapy-Related Gene Signature in Prostate Cancer. Cancers 2022, 14, 5032.

Paraskevi Kogionou, Sotirios P Fortis, Maria Goulielmaki

|Jul 29, 2023
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer.

Sotirios P Fortis, Panagiota Batsaki, Savvas Stokidis

|Mar 29, 2023
Frequencies of an Immunogenic HER-2/neu Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate Cancer.

Maria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou

|Feb 11, 2023
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival.

Chara Papalouka, Maria Adamaki, Panagiota Batsaki

Pageof 2

Frequent Collaborators

9 joint publications

Constantin N Baxevanis

3 joint publications

Maria Adamaki

3 joint publications

Angelos D Gritzapis

2 joint publications

Sotirios Ouzounis